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ABSTRACT
PURPOSE: To investigate if expression of genes encoding pro and anti-apoptotic proteins in the rat enteric endothelial cells stimulated 
by intestinal ischemia followed by reperfusion (IR) can be modified by treatment with heparin (HP). 
METHODS: Eighteen adult Wistar rats were divided in three groups: sham group submitted to laparotomy only (SG), ischemia 
followed by reperfusion group (IRG); ischemia followed by reperfusion plus pretreatment with HP 100 mg.kg-1 (IRG+HP). Ischemia 
was performed by clamping of the superior mesenteric artery. After 60 min of ischemia, metal clamps were removed for reperfusion 
for 120 min. Gene expression of encoding pro (Casp1, Casp6, Casp3, Cflar, Fas and Pgl) and anti-apoptotic (Bcl2, Bcl2l1 and Naip2) 
proteins in rat enteric endothelial cells was evaluated by PCR microarray method.
RESULTS: Compared to rat endothelial cells of SG, the expression of pro-apoptotic genes was up-regulated in IRG while anti-apoptotic 
genes were down-regulated. In contrast, the expression of anti-apoptotic genes in IRG+HP was up-regulated while pro-apoptotic genes 
was down-regulated compared to SG.
CONCLUSION: The attenuation by heparin of intestinal ischemia-reperfusion previously demonstrated in rodents could be related 
with ability of this drug to stimulate and reduce gene expression of encoding anti and pro-apoptotic proteins, respectively. 
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Introduction
Ischemia followed by reperfusion (IR) triggers a multiple 
biological responses that cause tissue injury and loss of organ 
function. Although, oxygen is a critical substrate in the alleviation 
of ischemia, paradoxically, it also functions as a deleterious 
metabolite during the reperfusion of previously ischemic tissues1. 
It is important to note that IR injury is associated to organ 
transplants, major organ resections and in shock2.
The oxidative stress caused by IR may lead either to 
immediate cell death (necrosis), controlled cell death (apoptosis) 
or trigger changes of the cell phenotype in response to IR injury3,4. 
Pro and anti-apoptotic proteins are involved in the cascade of 
IR injury3,4. Some studies have proposed that the use of the 
quantitative real time polymerase chain reaction method (qRT-
PCR) to evaluate specific gene expression during IR could be 
crucial to understanding the biochemical mechanism and the 
effects of protective treatments3-4. It is assumed that proteins that 
function together in a pathway or structural complex are likely to 
evolve in a correlated fashion3-4.
Pharmacological studies have proposed the use of 
different class of drugs to attenuate or prevent the structural and 
functional lesions caused by IR5. Recent studies have suggested 
that glycosaminoglycan heparin (HP) and its derivatives, agents 
currently used as anticoagulant and antithrombotic, act as free 
radical scavengers and inhibitors of apoptosis in several cell types, 
protecting them from IR injury6-7.  The initial endothelial damage 
plays a main role in IR, but the limited access to endothelial tissue 
is a major constraint when investigating the cellular mechanisms 
of vascular inflammation1-4.
Using Rat Endothelial Cell Biology PCR microarray, we 
decided to investigate if intestinal IR modifies gene expression 
encoding pro and anti-apoptotic proteins in the rat enteric 
endothelial cells and if HP treatment modifies this response.
Methods
All experimental protocols used in the present study 
were approved by the Ethics Committee in Research of the 
Federal University of Sao Paulo (UNIFESP) on according to 
the recommendations of the international legislations on animal 
protection (CEP 0362/11). The study was designed as a randomized 
controlled trial with a blinded assessment of the outcome. 
Eighteen male Wistar-EPM1 rats weighed 250 to 300g 
were obtained of Center for the Development of Experimental 
Models for Medicine and Biology - CEDEME-UNIFESP). 
The animals were housed under controlled temperature and 
light conditions with a 12h light/dark cycle, and free access 
to water and standard pellet chow until 6h prior to the surgical 
procedures. All procedures were conducted in the laboratories of 
Animal Experimentation of Department of Surgery, Morphology, 
Biochemistry and Pharmacology of the UNIFESP.
The animals underwent anesthesia (intramuscular 
injection of 80 mg.kg-1 ketamine and 10 mg.kg-1 xylazine), median 
laparotomy, and exposure of the superior mesenteric vessels and 
were randomly divided in three groups:
Sham group (SG, n=6): These animals were submitted to 
laparotomy without clamping of superior mesenteric artery; 
Ischemia and reperfusion group (IRG, n=6): These 
animals were submitted to laparotomy and clamping of superior 
mesenteric vessels for 60 min followed by 120 min of reperfusion; 
saline solution 0.9% was inject in the femoral vein 5 min before 
ischemia, 5 min after reperfusion and 55 min of reperfusion; 
Ischemia and reperfusion and heparin group (IRG+HP, 
n=6): These animals were submitted to laparotomy and clamping 
of superior mesenteric vessels for 60 min followed by 120 min of 
reperfusion; HP 100 mg.kg-1  was inject in the femoral vein 5 min 
before ischemia, 5 min after reperfusion and 55 min of reperfusion. 
In all groups, after 180 min of IR, intestinal segments 
(3 cm) were removed at distance of 20 cm from the duodenum-
jejunum flexure, opened longitudinally, gently washed in saline 
solution 0.9%, wrapped in aluminum foil, and immediately 
freezing in liquid nitrogen for storage in ultralow freezer. After 
this, euthanasia of animals was performed by intravenous injection 
of embutamide, mebezone and tetracain mixture.
The tissue samples from each group were prepared to 
assays using Endothelial Cell Biology Rat RT² Profiler™ PCR 
microarray method (SA Biosciences - Qiagen Co, USA). These 
assays were performed according to the manufacturer’s protocol. 
Briefly, total RNA was extracted from tissues using Trizol reagent 
(Life Technologies, USA) and purified using an RNeasy MiniKit 
(SA Biosciences - Qiagen Co, USA). Concentration of each total 
RNA sample was determined by spectrophotometry, and the 
quality was assessed by electrophoresis on 2% agarose gels. The 
first strand complementary DNA (cDNA) was synthesized using 
1 µg of total RNA and the RT² First Strand Kit (SA Biosciences - 
Qiagen Co, USA). Equal amounts of cDNA and the Master Mix 
SYBR® Green qPCR Mastermix (SA Biosciences - Qiagen Co, 
USA) were distributed to each well of the PCR microarray plate 
containing the pre-dispensed gene-specific primer sets. PCR was 
performed according to the manufacturer’s instructions in 96-well 
plates to detect the expression of 84 genes related to oxidative 
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stress, five housekeeping genes (ACTB, Gapdh, Hsp90ab1, Hprt1, 
Gusb) used for normalizing the PCR microarray data, and one 
negative control for genomic DNA contamination. The negative 
control primer set specifically detects non-transcribed, repetitive 
genomic DNA with a high level of sensitivity. Three wells of 
reverse transcription controls (RTCs) were used to verify the 
efficiency of the RT reaction with a qPCR assay that specifically 
detects template synthesized from the RNA control of the first 
strand synthesis kit. The replicate positive PCR controls (PPCs) 
were used to determine the efficiency of the polymerase chain 
reaction itself. These controls use a pre-dispensed artificial DNA 
sequence and a specific primer set to detect it. The two sets of 
replicate control wells (RTCs and PPCs) also test for inter-well 
and intra-plate consistency. The instrument’s software (MxPro 
Equipment Real Time Systems, Stratagene, GE, Co, USA) 
calculates the threshold cycle (Ct) values for all of the genes in the 
array. Finally, it performs pair-wise comparisons by calculating 
fold changes in gene expression from the raw threshold cycle 
data using the ΔΔCt method. The method used in our study to 
determine the relative expression levels of the genes of interest in 
each sample is contained in the spreadsheet for PCR Array Data 
Analysis v3.3 (SA Biosciences - Qiagen Co, USA).
Statistical analysis
The analysis of gene expression by real-time PCR 
represents a relative quantification of genes of interest. The 
control samples (SG) was used as reference baseline. The results 
were transformed into log2 scale for the calculation of averages 
and standard errors and for statistical analysis. Fold-change [2^ 
(- Delta Delta Ct)] is the normalized gene expression [2^ (- Delta 
Ct)] in the Test Sample (IRG or IRG+HP) divided the normalized 
gene expression [2^ (-Delta Ct)] in the Control Sample (SG). 
Fold-regulation represents fold-change results in a biologically 
meaningful way. It was considered that fold-change values greater 
than one indicates a positive or an up-regulation, and the fold-
regulation is equal to the fold-change. The p values are calculated 
based on a Student’s t-test of the replicate 2^ (-Delta Ct) values 
for each gene in the control group and treatment groups. P values 
less than 0.05 was considered significant in all experiments and 
indicated by symbols.
Results
Table 1 and Figure 1 shows the expression levels of 
ten genes related to rat enteric endothelial cell biology from SG, 
IRG, IRG+HP. Table 1 shows the lists of studied genes and its 
abbreviations (alphabetical order), descriptions and expression 
(up or down regulation). 
FIGURE 1 - Scatter plot showing up (+) and down (-) fold-regulation 
of gene expression related to endothelial cell biology from rats of sham 
group (SG) versus ischemic and reperfusion group (IRG) and sham group 
(SG) versus ischemic and reperfusion plus heparin group (IRG+HP).
# Bank Symbol IRG IRG+HP P value
1 NM_017059 Bax +1.48 +9.69 0.000002*
2 NM_016993 Bcl2 +3.86 +13.50 0.000003*
3 NM_031535 Bcl2l1 +1.01 +22.89 0.000002*
4 NM_012762 Casp1 +100.68 +17.94 0.000018*
5 NM_012922 Casp3 +8.28 +1.43 0.007822*
6 NM_031775 Casp6 +6.86 +3.55 0.000026*
7 NM_057138 Cflar +41.60 +0.63 0.000175*
8 NM_139194 Fas +23.73 +6.96 0.000007*
9 XM_226742 Naip2 +1.31 +9.33 0.000087*
10 XM_574314 Plg +6.69 +10.85 0.000264*
  (*)p≤0.05 
TABLE 1 - Expression of ten genes related to enteric endothelial 
cell biology from rats of sham (SG), ischemia and reperfusion (IRG) and 
ischemic and reperfusion plus heparin (IRG+HP) groups.  Significant 
values of fold up (+) or down (-) regulation was marked in bold [2^ (- 
Delta Ct]. 
Compared to SG, pro-apoptotic gene expression (Casp1, 
Casp3, Casp6, Cflar, Fas and Pgl) was up-regulated while anti-
apoptotic gene expression (Bcl2, Bcl2l1 and Naip2) was down-
regulated in IRG (increase of apoptosis). In contrast, anti-
apoptotic gene expression was up-regulated while pro-apoptotic 
gene expression was down-regulated in IRG+HP. 
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Discussion
The complex mechanisms involving cellular death 
after IR injury are not fully understood. Significant increases of 
content of reactive oxygen species (ROS) in tissues exposed to 
IR have been observed. In these tissues were showed increment 
of hydroxyl radicals, superoxide anions, and hydrogen peroxide, 
associated with decreased antioxidant enzyme activities8,9. ROS 
play a major role in the pathophysiology of the ischemic injury via 
oxidative damage to membrane lipids and proteins8,9.
Superoxide dismutase (SOD) represents the first 
line of defense against oxidative stress, by catalyzing the 
dismutation reaction of superoxide anion to hydrogen peroxide8-10. 
Malondialdehyde (MDA), one of the major products of lipid 
peroxidation, has been extensively measured as an index of this 
process10. In addition, intracellular Ca2+ overload destabilizes the 
cellular function and architecture, resulting in damage and eventual 
cell death10. This Ca2+ overload is caused by multiple mechanisms, 
but mainly by influx by voltage-gated Ca2+ channels and release from 
Ca2+ the intracellular organelles, such as endoplasmic reticulum10. 
In vascular endothelial cells, thrombin induces 
increment of cytosolic Ca2+ levels and subsequent nitric oxide 
(NO) production11. Thrombin cleaves protease-activated receptors 
resulting in activation of intracellular signals11. Ca2+  plays a unique 
role in the pathophysiology of ischemia, because it causes several 
damaging events by activating a variety of Ca2+-dependent enzymes, 
including protein kinase C, phospholipase A2, phospholipase 
C, cyclooxygenase, Ca2+-dependent nitric oxide synthase, and 
calpain, as well as various proteases and endonucleases10-12. As a 
result of the formation of cytotoxic products, such as free radicals 
and leukotrienes, excess intracellular Ca2+ triggers irreversible 
mitochondrial damage, inflammation, and programmed cell death 
(apoptosis) and/or necrotic10-12.
Using Endothelial Cell Biology Rat PCR microarray 
method, we showed that gene expression encoding of pro-
apoptotic proteins (Casp1, Casp3, Casp6, Cflar, Fas and Pgl) was 
up-regulated while anti-apoptotic gene expression (Bcl2, Bcl2l1 
and Naip2) was down-regulated in rats submitted to intestinal 
IR (Figure 1 and Table 1). These results indicate an increment of 
apoptotic process in endothelial cells injured by IR. In contrast, 
pretreatment with HP produced an increase of anti-apoptotic 
gene expression accompanied by reduction of pro-apoptotic gene 
expression in endothelial cells of rats submitted to IR (Figure 
1 and Table 1), indicating that HP treatment is able to attenuate 
apoptotic process in response to intestinal IR injury. 
It is well documented that HP and its derivates produce a 
protector effect in tissue/organs submitted to IR injury6,7,11,13-18,20,21. 
This effect appear be mediated by various cellular actions of HP 
and its derivates, including free radical scavenger and inhibition of 
apoptotic process in cell and tissues exposed to IR injury6,7,11,13-18. 
However, molecular mechanisms involved in these cytoprotector 
actions remain yet under investigation. 
HP and its derivatives have long been proposed for stroke 
treatment. HP may prevent venous thromboembolic complications, 
improve neurologic outcomes, reduce mortality, and prevent 
early recurrence. Some low-molecular-weight HP (LMWH), as 
nadroparin and tinzaparin, has been tested in the treatment of acute 
IR lesions13-18. Studies published from 2009 to 2012 by Taha et 
al.19 using animal model of hepatic IR showed that HP attenuated 
hepatic lesions caused by IR in rats and rabbits. For example, 
Taha et al.19 showed that protective effects of HP on hepatic IR 
injury in rabbits could be partly mediated by controlling by HP of 
aspartate aminotransferase, alanine aminotransferase, and lactate 
dehydrogenase levels. In addition, histological analysis showed 
significant reduction in cellular lesions caused by IR among livers 
of HP-treated rabbits. 
Celik et al.20 showed that HP treatment in animals 
submitted to IR attenuated flap necrosis and improved survival 
owing to radical scavenging, antioxidant effects, and supportive 
activities on capillary permeability and transudation. Medeiros et 
al.21 showed that HP treatment in animals submitted to IR stimulated 
intracellular calcium release, activation of phospholipase C and 
of calcium calmodulin kinase II, NO production and vascular 
protective factors. 
These results indicate that attenuation by HP of intestinal 
IR injury previously demonstrated in rodents could be related with 
ability of this drug to modulate expression of proteins involved 
in apoptotic response, by up-regulation of genes encoding anti-
apoptotic proteins and down-regulation of genes encoding pro-
apoptotic proteins.  
Conclusion
The pretreatment with heparin was demonstrated in 
rodents that could be related with ability of this drug to stimulate 
and reduce gene expression of encoding anti and pro-apoptotic 
proteins, respectively.
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